GVHD, ACUTE
Clinical trials for GVHD, ACUTE explained in plain language.
Never miss a new study
Get alerted when new GVHD, ACUTE trials appear
Sign up with your email to follow new studies for GVHD, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in preventing transplant complications
Disease control CompletedThis early-phase study tested whether adding a drug called BMS-986004 (which blocks CD40-L) to standard immune-suppressing medicine could help prevent acute graft-versus-host disease (GVHD) in 45 adults with blood cancers or disorders receiving a stem cell transplant. GVHD is a s…
Matched conditions: GVHD, ACUTE
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 09, 2026 05:19 UTC
-
Blood markers may predict transplant complication risk
Knowledge-focused CompletedThis study looked at 500 patients who received a stem cell transplant for blood cancers. Researchers measured certain proteins in the blood to see if they could help predict or diagnose acute graft-versus-host disease (aGVHD), a common and serious complication. The goal was to im…
Matched conditions: GVHD, ACUTE
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC